Strategies to detect and treat MSM with acute infection may be a powerful tool to control HIV epidemics
Long-acting GSK1265744 and TMC278-LA appear safe and practical in early study
No increase in risk behaviour in people taking antiretroviral therapy, meta-analysis shows
First-line antiretroviral therapy has improved over time, meta-analysis shows
Intervention with cash lottery prizes cuts HIV infection by 39% in young women in Lesotho
Ambitious plans for treatment as prevention in Asia, but challenges remain
Dolutegravir superior to raltegravir for treatment-experienced people with HIV
Reduced efavirenz dose suppresses HIV as well as standard dose
Study supports WHO recommendations for second-line HIV therapy in resource-limited countries
